Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    Rebiotix
Show Display Options
Rank Status Study
1 Recruiting Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection
Condition: Recurrent Clostridium Difficile Infection
Interventions: Biological: RBX2660 (microbiota suspension);   Other: Placebo
2 Completed Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea
Condition: Recurrent Clostridium Difficile Infection
Intervention: Biological: RBX2660 (microbiota suspension)

Indicates status has not been verified in more than two years